Viewing Study NCT04225260


Ignite Creation Date: 2025-12-25 @ 2:09 AM
Ignite Modification Date: 2025-12-26 @ 5:06 AM
Study NCT ID: NCT04225260
Status: COMPLETED
Last Update Posted: 2023-06-18
First Post: 2020-01-07
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Long-term Treatment of Moderate to Severe Glabellar Lines and Lateral Canthal Lines
Sponsor: Galderma R&D
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2020-01-27
Start Date Type: ACTUAL
Primary Completion Date: 2021-04-12
Primary Completion Date Type: ACTUAL
Completion Date: 2021-05-21
Completion Date Type: ACTUAL
First Submit Date: 2020-01-07
First Submit QC Date: None
Study First Post Date: 2020-01-13
Study First Post Date Type: ACTUAL
Results First Submit Date: 2023-05-23
Results First Submit QC Date: None
Results First Post Date: 2023-06-18
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: 2021-05-28
Disp First Post Date Type: ACTUAL
Last Update Submit Date: 2023-05-23
Last Update Post Date: 2023-06-18
Last Update Post Date Type: ACTUAL